Whalesbook
India bana multi-omics research ka hub!
Reliance Industries ki company, Strand Life Sciences, ne apne naye Olink Explore HT proteomics service se India ko multi-omics research mein aage badha diya hai. Yeh service genomics aur bioinformatics ko jod kar complex bimariyon ko samajhne aur targeted therapies ko jaldi develop karne mein madad karegi.
Proteomics Market ka Future India mein
Indian proteomics market mein zabardast growth hone wali hai. Experts predict kar rahe hain ki 2026 se 2034 tak iska CAGR 7.98% rahega aur yeh $2,934.5 million tak pahunch jayega. Cancer rates ka badhna, early aur precise diagnostics ki zaroorat, aur liquid biopsies jaisi technologies mein progress iske main reasons hain.
Reliance Industries ki strategy
Reliance Industries, jo ek badi Indian conglomerate hai, apni Strand Life Sciences ke through proteomics mein invest karke advanced technology sectors mein expand kar rahi hai. Company ki market cap ₹17.89 trillion hai. S&P Global ne recently inki credit rating ko upgrade karke 'A-' kar diya hai.
Olink Technology aur Thermo Fisher ka deal
Strand Life Sciences jo Olink Explore HT technology use kar rahi hai, woh Olink Holding AB ki hai. Olink ko Thermo Fisher Scientific ne ~$3.1 billion mein acquire kiya hai. Is deal se Thermo Fisher apni life sciences platforms ko aur mazboot karega.
Proteomics market mein competitors
Proteomics market mein Quanterix, MSD, aur Luminex jaise players hain. Bade naam jaise Thermo Fisher Scientific, Danaher Corporation, aur Agilent Technologies bhi advanced analytical platforms aur AI tools mein invest kar rahe hain.
Olink ka financial outlook
Olink Holding AB ko financials mein kuch challenges face karne pad rahe hain. Unhone Q1 2024 mein $(16.1) million ka net loss report kiya hai. Thermo Fisher Scientific ke subsidiary hone ke naate, Olink ki future strategy parent company ke goals ke hisaab se hogi.
India ke Biotech Sector ka potential
Reliance ki Strand Life Sciences dwara advanced proteomics services launch karne se India ka biotechnology aur precision medicine sector kafi boost hoga. Indian proteomics market ki projected growth aur global multi-omics advancements India ko life sciences research mein ek important player banayenge.